|
Molecular Targets Development
Program
|
|
Collaborative Research Opportunities |
|
|
Other Discovery Tools
The MTDP welcomes opportunities to assist in the
development or application of other pertinent discovery tools, which might
include more specialized bioassays, screens, reagents or related technology of
interest to CCR investigators. The MTDP is eager to collaborate in the
evaluation or implementation of a broad range of available or evolving
"discovery" and validation technologies, including proprietary methods,
hardware, software, compounds or collections, from the private-sector. In so
doing, the MTDP intends to enhance the CCR's intramural capabilities for
follow-up investigations of screening hits, bioprobe or drug-lead discovery and
characterization, identification and validation of new molecular targets, and
other pertinent research supporting preclinical or clinical advancement of
molecular therapeutics, diagnostics and imaging.
|
|
|
© 2000-2005 Center for Cancer Research
at the National Cancer Institute. questions, comments, and suggestions to
webmaster Last modified Novembher
18, 2005 |
|
Home |
Mission | Organization| News |
|
|